Database of Patients Treated With Metabolic Radiotherapy and Their Samples
Collects clinical data and samples from adults with thyroid, prostate or other tumors.
Plain-language title generated from the registry record
Registry title: Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department
Key facts
- Where
- Bordeaux, Marseille, Montpellier, and Toulouse, FranceSee the 4 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults treated with metabolic radiotherapy in a nuclear medicine department for thyroid cancer, a neuroendocrine tumour (or other SSTR positive tumour such as meningioma) or prostate cancer. They must agree to an extra blood sample.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Thyroid cancer, neuroendocrine tumour or other SSTR positive tumour (such as meningioma) treated with PRRT, or prostate cancer.
- Earlier treatment
- Must be treated with metabolic radiotherapy in the Nuclear Medicine Department.
- Biomarker or test result
- SSTR positive tumour for the PRRT group.
Main reasons for not taking part
- Not affiliated to a social security scheme
- Under tutelage, curatorship or safeguard of justice
- In an emergency situation
- Regular follow-up seems impossible for psychological, family, social or geographical reasons
- Pregnant or breastfeeding
Read by machine on 12 November 2026.
Where in France
- Hôpital Haut LévêqueBordeaux, FranceContact: Elif HINDIE, MDTaking people
- Hôpital LaTimoneMarseille, FranceContact: David TAIEB, MDNot yet recruiting
- Centre Regional de Lutte Contre le Cancer - Centre Val d'AurelleMontpellier, FranceContact: Marc Ychou, MD, PhDTaking people
- Institut universitaire du cancer de ToulouseToulouse, FranceContact: Lawrence DIERICKX, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Institut du Cancer de Montpellier - Val d'Aurelle
- Trial code
- NCT04104529
- Record updated
- 12 November 2026
- Original description
Development of a clinico-biological database allowing the provision of clinical data and corresponding biological materials to the medical and scientific community.Read full original descriptionShow less
Establishment of a Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department
Development of a clinico-biological database allowing the provision of clinical data and corresponding biological materials to the medical and scientific community.
Inclusion: Age ≥ at 18 years old,; Patient treated in the Nuclear Medicine Department for the treatment by metabolic radiotherapy,; Patient treated as part of his treatment for:; thyroid cancer,; a neuroendocrine tumor or any SSTR positive tumours (like meningiomas) receiving PRRT; prostate cancer; Patient having accepted the complementary blood sample,; Patient having given his informed, written and express consent.
Exclusion: Patient not affiliated to a social security scheme,; Subject under tutelage, curatorship or safeguard of justice,; Patient in an emergency situation; Patient whose regular monitoring is a priori impossible for psychological, family, social or geographical reasons,; Pregnant and / or breastfeeding woman.